TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituxima…
Biotechnology
US, New York [HQ]
Growth Rates · Payout · Yield
Dividends Over Time
Growth Rates · Payout · YieldSearching for a Dividend Aristocrat? Sign Up to view the entire dividend history of TG Therapeutics, Inc.
Growth Rates
0.00%
YoY
0.00%
3Yr
0.00%
5Yr
0.00%
10Yr
Key Metrics
- -%
TTM Yield
- -
Average Days Gap
Series
- -%
Yield
0.00%
Payout Ratio
History
We could not find any dividend history for TG Therapeutics, Inc..